0001209191-15-051663.txt : 20150609 0001209191-15-051663.hdr.sgml : 20150609 20150609203416 ACCESSION NUMBER: 0001209191-15-051663 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150327 FILED AS OF DATE: 20150609 DATE AS OF CHANGE: 20150609 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001297184 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330702205 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 BUSINESS PHONE: 909-980-9484 MAIL ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Luo Mary Z. CENTRAL INDEX KEY: 0001611156 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36509 FILM NUMBER: 15922137 MAIL ADDRESS: STREET 1: 11570 6TH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zhang Jack Y. CENTRAL INDEX KEY: 0001611157 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36509 FILM NUMBER: 15922138 MAIL ADDRESS: STREET 1: 11570 6TH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-03-27 0 0001297184 Amphastar Pharmaceuticals, Inc. AMPH 0001611157 Zhang Jack Y. C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730 1 1 1 0 CEO & Chief Science Officer 0001611156 Luo Mary Z. C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730 1 1 1 0 COO, Chief Scientist, Chairman Common Stock 2015-03-27 4 F 0 20877 15.43 D 911636 D Common Stock 2015-06-05 4 M 0 48980 12.97 A 960616 D Common Stock 2015-06-05 4 S 0 44149 16.4642 D 916467 D Common Stock 2015-06-08 4 M 0 30066 12.97 A 946533 D Common Stock 2015-06-08 4 S 0 27020 16.614 D 919513 D Common Stock 2015-06-09 4 M 0 28324 12.97 A 947837 D Common Stock 2015-06-09 4 S 0 25700 16.2356 D 922137 D Common Stock 2015-03-27 4 F 0 8641 15.43 D 661666 I See footnote Common Stock 2015-06-05 4 M 0 50162 12.97 A 711828 I See footnote Common Stock 2015-06-05 4 S 0 43989 16.4657 D 667839 I See footnote Common Stock 2015-06-08 4 M 0 30152 12.97 A 697991 I See footnote Common Stock 2015-06-08 4 S 0 27100 16.6087 D 670891 I See footnote Common Stock 2015-06-09 4 M 0 28433 12.97 A 699324 I See footnote Common Stock 2015-06-09 4 S 0 25800 16.1229 D 673524 I See footnote Common Stock 7631594 I See footnote Common Stock 5000 I See footnote Common Stock 200000 I See footnote Employee Stock Option (right to buy) 12.97 2015-06-05 4 M 0 48980 0.00 D 2015-09-28 Common Stock 48980 226020 D Employee Stock Option (right to buy) 12.97 2015-06-08 4 M 0 30066 0.00 D 2015-09-28 Common Stock 30066 195954 D Employee Stock Option (right to buy) 12.97 2015-06-09 4 M 0 28324 0.00 D 2015-09-28 Common Stock 28324 167630 D Employee Stock Option (right to buy) 12.97 2015-06-05 4 M 0 50162 0.00 D 2015-09-28 Common Stock 50162 134838 I See footnote Employee Stock Option (right to buy) 12.97 2015-06-08 4 M 0 30152 0.00 D 2015-09-28 Common Stock 30152 104686 I See footnote Employee Stock Option (right to buy) 12.97 2015-06-09 4 M 0 28433 0.00 D 2015-09-28 Common Stock 28433 76253 I See footnote The reported securities were withheld to satisfy the Reporting Person's tax liability in connection with the vesting of deferred stock units (DSUs). The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the each of the reporting persons on December 16, 2014. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.28 to $16.5015, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5), (7), (8) and (9) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.41 to $16.85, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $16.595, inclusive. The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.28 to $16.52, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.41 to $16.825, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.595, inclusive. The shares are held of record by Applied Physics & Chemistry Laboratories, Inc., of which the reporting persons are the sole owners. The shares are held of record in an account for the benefit of the reporting persons' son. The reporting persons disclaims beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose. The shares are held of record by a trust for the benefit of the reporting persons' son. The reporting persons disclaims beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose. Shares subject to the option are fully vested and immediately exercisable. /s/ Ken Stupak, by power of attorney for Jack Y. Zhang 2015-06-09 /s/ Ken Stupak, by power of attorney for Mary Z. Luo 2015-06-09